- Elucidates the recent advances in nuclear medicine and molecular imaging technologies Broadens readers’ understanding of the application of nuclear medicine and molecular imaging
- Offers many insights into integrated medical therapy and future drug development
This work is devoted to understanding the recent advances in nuclear medicine and molecular imaging technologies along with their application to integrated medical therapy and future drug development.
This anthology is based on the international symposium in 2015 entitled
Perspective on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy. The symposium provided an opportunity to exchange ideas on how to promote nuclear medicine technology and how to extend the technology to medical therapy and drug development, and was also a good opportunity to discuss the future perspective of nuclear medicine and molecular imaging by worldwide leaders in the field. Molecular imaging technologies have been rapidly developed worldwide in recent years. Among those developments, nuclear medicine has come to play an important role in quantitative analysis of biological process in vivo as well as in wide clinical use. With the current progress of nuclear medicine and molecular imaging, this modality has been applied for treatment monitoring and predicting its outcome with the use of optimal imaging biomarkers and suitable quantitative analysis.
Table of ContentsPart I Instrument and Data Analysis
- 1 Advances in 4D Gated Cardiac PET Imaging for Image Quality Improvement and Cardiac Motion and Contractility Estimation
- 2 The Need for Quantitative SPECT in Clinical Brain Examinations
- 3 PET Imaging Innovation by DOI Detectors
- 4 Semiconductor Detector-Based Scanners for Nuclear Medicine
- 5 Kinetic Analysis for Cardiac PET
Part II Biomarker and Molecular Probes
- 6 How Far Are We from Dose On Demand of Short-Lived
Radiopharmaceuticals? - 7 Advantages of Radiochemistry in Microliter Volumes
- 8 Development of a Microreactor for Synthesis of 18F-Labeled
Positron Emission Tomography Probe - 9 Preclinical Evaluation of a Thymidine Phosphorylase Imaging Probe, [123I]IIMU, for Translational Research
- 10 Discovery and Evaluation of Biomarkers for Atherosclerosis
- 11 Radioimmunodetection of Atherosclerotic Lesions Focusing on the
Accumulation Mechanism of Immunoglobulin G
Part III Cardiology
- 12 Noninvasive PET Flow Reserve Imaging to Direct Optimal Therapies for Myocardial Ischemia
- 13 The Clinical Value of Cardiac PET in Heart Failure
- 14 Emerging Trends and Future Perspective of Novel Cardiac
SPECT Technology - 15 Right Ventricular Metabolism and Its Efficiency
- 16 Usefulness of 18F-FDG PET in Diagnosing Cardiac Sarcoidosis
Part IV Neurology
- 17 PET Quantification in Molecular Brain Imaging Taking into Account the Contribution of the Radiometabolite Entering the Brain
- 18 Hypoxia Imaging with 18F-FMISO PET for Brain Tumors
- 19 Evolution and Protection of Cerebral Infarction Evaluated by PET and SPECT
- 20 Brain Development and Aging Using Large Brain MRI Database
Part V Oncology
- 21 Back to the Future: Nuclear Medicine Rediscovers Its Therapeutic Roots
- 22 Interactive Communication Between PET Specialists and Oncologists
- 23 Clinical Efficacy of PET/CT Using 68Ga-DOTATOC for Diagnostic Imaging
- 24 Correlation of 40-[methyl-11C]-Thiothymidine Uptake with Ki-67
Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas - 25 Impact of Respiratory-Gated FMISO-PET/CT for the Quantitative Evaluation of Hypoxia in Non-small Cell Lung Cancer
